NCT05165641

Brief Summary

Providing safe and efficient anesthesia and in a field hospital is a challenging situation. This study investigated the feasibility and safety of thoracic spinal anesthesia for small-incision open cholecystectomy in a deployed field hospital.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 10, 2017

Completed
4.4 years until next milestone

First Posted

Study publicly available on registry

December 21, 2021

Completed
Last Updated

November 15, 2022

Status Verified

November 1, 2022

Enrollment Period

1.2 years

First QC Date

August 10, 2017

Last Update Submit

November 13, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Feasibility of segmental spinal anesthesia for small-incision open cholecystectomy in a field hospital

    Patients' peroperative pain scores assessed on a numeric rating scale ranging from 0 (no pain) to 10 (worst possible pain)

    intraoperatively

  • Hemodynamic tolerance of segmental spinal anesthesia.

    Heart rate (beats per minute): monitored and recorded every 5 minutes:

    intraoperatively

  • Hemodynamic tolerance of segmental spinal anesthesia.

    Non-invasive blood pressure (mmHg): monitored and recorded every 5 minutes:

    intraoperatively

  • Respiratory safety of segmental spinal anesthesia.

    Respiratory rate (breaths per minute): monitored and recorded every 5 minutes.

    intraoperatively

  • Respiratory safety of segmental spinal anesthesia.

    Pulse oximetry (%): monitored and recorded every 5 minutes.

    intraoperatively

Secondary Outcomes (3)

  • surgeon's satisfaction with anesthesia technique

    intraoperatively

  • patient satisfaction with anesthesia technique

    24 hours postoperatively

  • postoperative adverse effects

    24 hours postoperatively

Study Arms (1)

segmental spinal anesthesia

OTHER

thoracic spinal anesthesia at T 10 level

Procedure: segmental spinal anesthesia

Interventions

Spinal anesthesia was performed at a lower thoracic level with the patient in the sitting position. After local anesthesia with 1% lidocaine, the spinal puncture was done in the 10th thoracic intervertebral space (T 10) through a median approach. A 27 Gg pencil-point needle with an introducer was used (marquee). To identify T 10, the vertebra prominens (C7) was palpated and the spinous processes were palpated caudally \[ref}. Two senior anesthesiologists performed all the spinal punctures. The progression of the spinal needle was cautious and soft. The effort was made to stop the needle progression just after the tactile perception of the dura mater. Once the flow of cerebrospinal fluid was obtained, 1.5 ml of hyperbaric bupivacaine 5mg/ml (=7.5 mg) mixed with 0.5 ml of fentanyl 50 µg/ml (= 25 µg) was injected and the spinal needle removed.

segmental spinal anesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • uncomplicated symptomatic cholelithiasis
  • American society of anesthesiologists (ASA) physical status I, II, or III

You may not qualify if:

  • patients with acute cholecystitis
  • suspected common bile duct stones
  • previous abdominal surgery
  • bleeding diathesis
  • spinal abnormality
  • allergy to any drug used in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Gallstones

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Younes Aissaoui

    Avicenna Military Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of anesthesia and intensive care medicine

Study Record Dates

First Submitted

August 10, 2017

First Posted

December 21, 2021

Study Start

February 1, 2016

Primary Completion

March 31, 2017

Study Completion

March 31, 2017

Last Updated

November 15, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share